1-20 of 20
David Huntsman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR002: Proteomic profiling of endometrial carcinomas

Dawn R. Cochrane, Gian Luca Negri, Jutta Huvila, Juliana Sobral de Barros, Forouh Kalantari, Nissreen Mohammad, David Farnell, Emily Thompson, Amy Lum, Sandra E. Spencer, Amy Jamieson, Samuel Leung, Derek Chiu, Martin Koebel, Stefan Kommoss, Friedrich Kommoss, Blake Gilks, Lien Hoang, David Huntsman, Gregg B. Morin, Jessica N. McAlpine
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5_Supplement): PR002.
https://doi.org/10.1158/1557-3265.ENDO24-PR002
Published: 01 March 2024
View article titled, Abstract PR002: Proteomic profiling of endometrial carcinomas
Journal Articles

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Kelly L. Bolton, Denise Chen, Rosario Corona de la Fuente, Zhuxuan Fu, Rajmohan Murali, Martin Köbel, Yanis Tazi, Julie M. Cunningham, Irenaeus C.C. Chan, Brian J. Wiley, Lea A. Moukarzel, Stacey J. Winham, Sebastian M. Armasu, Jenny Lester, Esther Elishaev, Angela Laslavic, Catherine J. Kennedy, Anna Piskorz, Magdalena Sekowska, Alison H. Brand, Yoke-Eng Chiew, Paul Pharoah, Kevin M. Elias, Ronny Drapkin, Michael Churchman, Charlie Gourley, Anna DeFazio, Beth Karlan, James D. Brenton, Britta Weigelt, Michael S. Anglesio, David Huntsman, Simon Gayther, Jason Konner, Francesmary Modugno, Kate Lawrenson, Ellen L. Goode, Elli Papaemmanuil
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4947–4956.
https://doi.org/10.1158/1078-0432.CCR-21-3817
Published: 14 November 2022
View article titled, Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Open the PDF for Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes in another window
Includes: Supplementary data
Journal Articles

Abstract B17: Modeling ovarian cancer in mice using in vivo electroporation and CRISPR-mediated genome editing

Keerthana Harwalkar, Katie Teng, Jocelyn Arceneau, Yifan Zhao, Dave Farnell, Matt Ford, Tuyet Nhung Tun Nu, David Huntsman, Yojiro Yamanaka
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B17.
https://doi.org/10.1158/1557-3265.OVCA19-B17
Published: 01 July 2020
View article titled, Abstract B17: Modeling ovarian cancer in mice using in vivo electroporation and CRISPR-mediated genome editing
Journal Articles

Abstract B30: The effect of OCP use on the incidence of precancerous p53 lesions in fallopian tube fimbria

Kendall Greening, Anthony Karnezis, Dawn Cochrane, David Farnell, Lien Hoang, Gillian Hanley, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B30.
https://doi.org/10.1158/1557-3265.OVCA19-B30
Published: 01 July 2020
View article titled, Abstract B30: The effect of OCP use on the incidence of precancerous p53 lesions in fallopian tube fimbria
Journal Articles

Abstract DP-006: THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRE-CANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA

Kendall Greening, Anthony Karnezis, Dawn Cochrane, Gillian Hanley, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): DP-006.
https://doi.org/10.1158/1557-3265.OVCASYMP18-DP-006
Published: 15 November 2019
View article titled, Abstract DP-006: THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRE-CANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA
Journal Articles

Abstract IA19: Granulosa cell and other rare ovarian cancers: Genomic-derived diagnostics and emergent management strategies

David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): IA19.
https://doi.org/10.1158/1557-3265.OVCA17-IA19
Published: 01 August 2018
View article titled, Abstract IA19: Granulosa cell and other rare ovarian cancers: Genomic-derived diagnostics and emergent management strategies
Journal Articles

Abstract B22: Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development

Zhouchunyang Xia, Dawn Cochrane, Michael Anglesio, Winnie Yang, Miguel Alcaide, Tayyebeh Nazeran, Janine Senz, Amy Lum, Ali Bashashati, Yikan Wang, Ryan Morin, Sohrab Shah, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B22.
https://doi.org/10.1158/1557-3265.OVCA17-B22
Published: 01 August 2018
View article titled, Abstract B22: Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development
Journal Articles

Abstract B39: The origins of endometriosis-associated cancers

Dawn Cochrane, Basile Tessier-Cloutier, Katherine Lawrence, Tayyebeh Nazeran, Anthony Karnezis, Clara Salamanca, Timothy Lee, Angela Cheng, Jessica McAlpine, Lien Hoang, Blake Gilks, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B39.
https://doi.org/10.1158/1557-3265.OVCA17-B39
Published: 01 August 2018
View article titled, Abstract B39: The origins of endometriosis-associated cancers
Journal Articles

Abstract NTOC-084: THE PROMISE OF COMBINATIONAL TREATMENT OF HISTONE DEACETYLASE 6 INHIBITOR ACY-1215 AND PROTEASOME INHIBITOR BORTEZOMIB IN SCCOHT

Yuting Shary Chen, Yemin Wang, Anthony Karnezis, Pilar Ramos, Holly Yine, Bernard Weissman, Jeffrey Trent, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-084.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-084
Published: 31 May 2017
View article titled, Abstract NTOC-084: THE PROMISE OF COMBINATIONAL TREATMENT OF HISTONE DEACETYLASE 6 INHIBITOR ACY-1215 AND PROTEASOME INHIBITOR BORTEZOMIB IN SCCOHT
Journal Articles

Abstract DPOC-014: BEYOND CODING MUTATIONS: USING RETROTRANSPOSONS TO PREDICT OVARIAN CANCER DEVELOPMENT

Zhouchunyang Xia, Dawn Cochrane, Michael S Anglesio, Tayyebeh M Nazeran, Janine Senz, Amy Lum, Ali Bashashati, Yi Kan Wang, Sohrab P Shah, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): DPOC-014.
https://doi.org/10.1158/1557-3265.OVCASYMP16-DPOC-014
Published: 31 May 2017
View article titled, Abstract DPOC-014: BEYOND CODING MUTATIONS: USING RETROTRANSPOSONS TO PREDICT OVARIAN CANCER DEVELOPMENT
Journal Articles

Abstract NTOC-090: TARGETING AND EFFICACY OF THE RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE, WORKS THROUGH INHIBITION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)

Jessica D. Lang, William Hendricks, Pilar Ramos, Holly Yin, Chris Sereduk, Jeffrey Kiefer, Yemin Wang, Anthony N. Karnezis, Bernard Weissman, David Huntsman, Jeffrey Trent
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-090.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-090
Published: 31 May 2017
View article titled, Abstract NTOC-090: TARGETING AND EFFICACY OF THE RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE, WORKS THROUGH INHIBITION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)
Journal Articles

Abstract AP32: THE METHYLTRANSFERASE EZH2 IS A VULNERABLE TARGET IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)

Yemin Wang, Shary Chen, Anthony Karnezis, Nancy Dos Santos, Pilar Ramos, Sarah Maines-Bandiera, Christine Chow, Bernard Weissman, Jeffrey Trent, David Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP32.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP32
Published: 31 May 2017
View article titled, Abstract AP32: THE METHYLTRANSFERASE EZH2 IS A VULNERABLE TARGET IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)
Journal Articles

Abstract POSTER-TECH-1119: Phylogenetic portraits of high grade serous ovarian cancer

Andrew McPherson, Andrew Roth, David Huntsman, Jessica McAlpine, Sohrab Shah
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-TECH-1119.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-TECH-1119
Published: 15 August 2015
View article titled, Abstract POSTER-TECH-1119: Phylogenetic portraits of high grade serous ovarian cancer
Journal Articles

The Kisspeptin and GPR54 ligand-receptor pair are associated with favorable prognosis and clear cell subtype in human ovarian carcinoma

Leah Prentice, Christian Klausen, Steve Kalloger, Martin Kobel, Steven McKinney, Ken Swenerton, Jennifer Santos, Blake Gilks, Peter Leung, David Huntsman, Samuel Aparicio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): B73.
Published: 15 August 2014
View article titled, The Kisspeptin and GPR54 ligand-receptor pair are associated with favorable prognosis and clear cell subtype in human ovarian carcinoma
Journal Articles

A new enrichment model for high sensitivity detection and downstream analyses of circulating tumor cells in breast cancer patients

Glenn Deng, Moshe Mishaeli, Melinda Miller, David Huntsman, Karen Gelmon, Rinat Yerushalmi, Edward Manna, David Krag, Jerry Williamson, Julian Burke
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15_Supplement): B19.
Published: 15 August 2014
View article titled, A new enrichment model for high sensitivity detection and downstream analyses of circulating tumor cells in breast cancer patients
Journal Articles

Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study

Daniel J. Sargent, Qian Shi, Sharlene Gill, Christophe Louvet, Richard B. Everson, Udo Kellner, Thomas E. Clancy, J. Marc Pipas, Murray B. Resnick, Michael O. Meyers, Tsung-Teh Wu, David Huntsman, Pierre Validire, Umar Farooq, Emily S. Pavey, Guillaume Beaudry, Jean-Francois Haince, Yves Fradet
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4361–4369.
https://doi.org/10.1158/1078-0432.CCR-13-2659
Published: 13 August 2014
View article titled, Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study
Open the PDF for Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study in another window
Includes: Supplementary data
Journal Articles

Abstract A17: FBxW7 duality in ovarian cancer: Novel insight into ovarian cancer pathogenesis

Elizabeth Louise Dickson, Lihua Li, Samuel Leung, Christine Chow, Rachel Isaksson Vogel, David Huntsman, C. Blake Gilks, Subbaya Subramanian
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A17.
https://doi.org/10.1158/1078-0432.OVCA13-A17
Published: 13 May 2014
View article titled, Abstract A17: FBxW7 duality in ovarian cancer: Novel insight into ovarian cancer pathogenesis
Journal Articles

Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy

Mark S. Carey, Roshan Agarwal, Blake Gilks, Kenneth Swenerton, Steve Kalloger, Jennifer Santos, Zhenlin Ju, Yiling Lu, Fan Zhang, Kevin R. Coombes, Dianne Miller, David Huntsman, Gordon B. Mills, Bryan T. Hennessy
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2852–2860.
https://doi.org/10.1158/1078-0432.CCR-09-2502
Published: 13 May 2010
View article titled, Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy
Open the PDF for Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Grace M. Callagy, Paul D. Pharoah, Sarah E. Pinder, Forrest D. Hsu, Torsten O. Nielsen, Joseph Ragaz, Ian O. Ellis, David Huntsman, Carlos Caldas
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2468–2475.
https://doi.org/10.1158/1078-0432.CCR-05-2719
Published: 25 April 2006
View article titled, Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
Open the PDF for Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index in another window
Journal Articles

Increased Expression of Integrin-Linked Kinase Is Correlated with Melanoma Progression and Poor Patient Survival

Derek L. Dai, Nikita Makretsov, Eric I. Campos, Changzheng Huang, Youwen Zhou, David Huntsman, Madgalena Martinka, Gang Li
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (12): 4409–4414.
Published: 10 October 2003
View article titled, Increased Expression of Integrin-Linked Kinase Is Correlated with Melanoma Progression and Poor Patient Survival
Open the PDF for Increased Expression of Integrin-Linked Kinase Is Correlated with Melanoma Progression and Poor Patient Survival in another window